| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...867743R |
| P356 | DOI | 10.1371/JOURNAL.PONE.0067743 |
| P932 | PMC publication ID | 3695867 |
| P698 | PubMed publication ID | 23840767 |
| P5875 | ResearchGate publication ID | 248386029 |
| P50 | author | Richard Dodel | Q30500712 |
| P2093 | author name string | Inga Zerr | |
| Jan-Philipp Bach | |||
| Yvonne Roettger | |||
| P2860 | cites work | 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. | Q51893579 |
| Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. | Q52487321 | ||
| Comparison of intravenous immunoglobulin preparations on microglial function in vitro: more potent immunomodulatory capacity of an IgM/IgA-enriched preparation. | Q52954728 | ||
| Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease. | Q53395492 | ||
| Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria | Q68012070 | ||
| A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture | Q71726212 | ||
| Cellular uptake of the prion protein fragment PrP106-126 in vitro | Q73254939 | ||
| Microglia and the pathogenesis of spongiform encephalopathies | Q73605054 | ||
| The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106--126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase | Q73794043 | ||
| Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia | Q74139800 | ||
| Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation | Q74650434 | ||
| Signal transduction during Fc receptor-mediated phagocytosis | Q28609863 | ||
| A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages | Q29616748 | ||
| Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner | Q34161546 | ||
| Five questions on prion diseases | Q34263032 | ||
| Molecular biology of prion diseases | Q34534878 | ||
| Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system | Q34963742 | ||
| Autoantibodies to alpha-synuclein in inherited Parkinson's disease. | Q35159805 | ||
| Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs). | Q35724430 | ||
| Mouse model recapitulating human Fcγ receptor structural and functional diversity | Q35924857 | ||
| Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages | Q36367162 | ||
| Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. | Q36400800 | ||
| Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia | Q36689356 | ||
| Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry | Q36857327 | ||
| A structural overview of the vertebrate prion proteins | Q37080692 | ||
| Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease | Q37118356 | ||
| Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders | Q37192880 | ||
| A versatile prion replication assay in organotypic brain slices | Q37369485 | ||
| Role of microglia in neuronal degeneration and regeneration | Q37599542 | ||
| Immunotherapy in prion disease | Q38068103 | ||
| Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. | Q40496060 | ||
| The IgG Fc receptor family | Q40847754 | ||
| Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B. Role of subplasmalemmal microfilaments | Q41182472 | ||
| Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease | Q41753192 | ||
| Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation | Q41860073 | ||
| Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. | Q41954090 | ||
| Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity | Q41975386 | ||
| Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. | Q42447316 | ||
| Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase | Q42799184 | ||
| Helix-coil transition of PrP106-126: molecular dynamic study | Q43825559 | ||
| High-yield isolation of murine microglia by mild trypsinization. | Q44645887 | ||
| Differential requirements for cellular cytoskeleton in human macrophage complement receptor- and Fc receptor-mediated phagocytosis | Q46404541 | ||
| Role of microglia in neuronal cell death in prion disease | Q47820922 | ||
| Fibrillar prion peptide (106-126) and scrapie prion protein hamper phagocytosis in microglia | Q47887915 | ||
| Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines | Q48234384 | ||
| Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity | Q48272962 | ||
| Neurotoxicity of a prion protein fragment | Q48304223 | ||
| Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration | Q48570765 | ||
| Microglial cells kill prion-damaged neurons in vitro by a CD14-dependent process | Q48729393 | ||
| Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden | Q48766393 | ||
| Role of microglia and host prion protein in neurotoxicity of a prion protein fragment | Q49050987 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prion protein family | Q24724413 |
| autoantibody | Q785022 | ||
| microglia | Q1622829 | ||
| P304 | page(s) | e67743 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein | |
| P478 | volume | 8 |
| Q90050705 | Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases |
| Q58696119 | Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein |
| Q64897506 | IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease. |
| Q40065603 | Immunization of cervidized transgenic mice with multimeric deer prion protein induces self-antibodies that antagonize chronic wasting disease infectivity in vitro. |
| Q34627859 | Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays |
| Q39125010 | α1-antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicity. |
Search more.